Treatment of Acute Yellow Fever Virus Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Treatment of Acute Yellow Fever Virus Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT03776786

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

Yellow Fever is an acute viral hemorrhagic disease caused by the Yellow Fever Virus (YFV), a re-emerging arbovirus transmitted by the same mosquito vector (Aede…

Singapore37 participantsStarted 2018-12-06

Treatment: TY014, 0.9% Saline